Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Oncology Reports|May 19, 2011
A phase I study of cisplatin, methotrexate, levofolinic acid and 5-fluorouracil in advanced squamous cell carcinoma of the head and neckF Caponigro, P Comella, A Daponte, et al.
Oncotargets and Therapy|March 19, 2019
Management of recurrent nasopharyngeal carcinoma: current perspectivesF Perri, G Della Vittoria Scarpati, F Caponigro, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2001
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerF Caponigro, C Dittrich, J B Sorensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, P Comella, F Rivellini, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Fotemustine and dacarbazine plus recombinant interferon alpha 2a in thetreatment of advanced melanomaP Comella, A Daponte, R Casaretti, et al.
European Journal of Cancer (Oxford, England : 1990)|May 25, 2005
Multicentre EORTC study 16997: feasibility and phase II trial of farnesyl transferase inhibitor & gemcitabine combination in salvage treatment of advanced urothelial tract cancersC Theodore, L Geoffrois, J B Vermorken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, E Massa, L Manzione, et al.
Oncology Reports|May 21, 2011
A phase-ii trial of 5-Fluorouracil, folinic Acid, vinorelbine in pretreated patients with metastic colorectal-cancerR Iaffaioli, G Facchini, A Tortoriello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancerR V Iaffaioli, A Tortoriello, G Facchini, et al.
Cancer Research|August 27, 1999
The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patientsP Thavasu, D Propper, A McDonald, et al.
Pageof 5